Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World-Reference-Cited by-同舟云学术

Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World

Published:2021-10-31 Issue:1 Volume:111 Page:44-51
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

McNair Douglas¹,Lumpkin Murray¹,Kern Steven¹,Hartman Daniel¹

Affiliation:

1. Global Health, Integrated Development Bill & Melinda Gates Foundation Seattle Washington USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2449

Reference33 articles.

1. Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions;Dodd C.;BMJ Glob. Health,2021

2. Real world evidence (RWE) – a disruptive innovation or the quiet evolution of medical evidence generation?;Khosla S.;F1000Res.,2018

3. Online tools to synthesize real‐world evidence of comparative effectiveness research to enhance formulary decision making;Chen S.;J. Manag. Care Spec. Pharm.,2021

4. Improving transparency to build trust in real‐world secondary data studies for hypothesis testing – why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative;Orsini L.S.;Value Health,2020

5. Impact of real‐world data on market authorization, reimbursement decision & price negotiation;Pulini A.A.;Ther. Innov. Regul. Sci.,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Research on Retinal Diseases Using Health Claims Database: A Narrative Review;Diagnostics;2024-07-19

2. Transferability of new methods for health technology assessment in the field of diabetes between early and late adopters’ countries;Biotechnology & Biotechnological Equipment;2024-06-25

3. The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report;Biologicals;2024-02

4. The value of using real-world evidence as a source of clinical evidence in the European medical device regulations: a mixed methods study;Expert Review of Medical Devices;2023-12-05

5. Data Challenges for Externally Controlled Trials: Viewpoint;Journal of Medical Internet Research;2023-04-05